Cargando…

Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences

Riociguat is a novel soluble guanylate cyclase stimulator that is approved for the treatment of patients with pulmonary arterial hypertension (PAH) and patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent/recurrent CTEPH after pulmonary endarterectomy (PEA). A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersen, Asger, Korsholm, Kasper, Mellemkjær, Søren, Nielsen-Kudsk, Jens Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476463/ https://www.ncbi.nlm.nih.gov/pubmed/28652963 http://dx.doi.org/10.1016/j.rmcr.2017.06.005

Ejemplares similares

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
por: Gall, Henning, et al.
Publicado: (2018)

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
por: Benza, Raymond L., et al.
Publicado: (2020)

Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study
por: Yang, Suqiao, et al.
Publicado: (2021)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
por: Barnikel, Michaela, et al.
Publicado: (2022)

Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”
por: Andersen, Asger
Publicado: (2018)

Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial
por: Andersen, Asger, et al.
Publicado: (2021)

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
por: Escribano-Subias, Pilar, et al.
Publicado: (2019)

Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
por: Korsholm, Kasper, et al.
Publicado: (2022)

Correction to: Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
por: Korsholm, Kasper, et al.
Publicado: (2022)

Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH
por: Moser, Bernhard, et al.
Publicado: (2014)

Left atrial appendage occlusion guided by intracardiac echocardiography in a patient with a 34 mm atrial septal defect occluder: a case report
por: Korsholm, Kasper, et al.
Publicado: (2023)

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
por: Kim, Nick H, et al.
Publicado: (2017)

Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching
por: Chamorro, Virginia, et al.
Publicado: (2018)

Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study
por: Aoki, Tatsuo, et al.
Publicado: (2020)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
por: Andersen, Stine, et al.
Publicado: (2016)

Spontaneously occluded left atrial appendage in a patient with atrial fibrillation and stroke: a case report
por: Tinggaard, Andreas Bugge, et al.
Publicado: (2020)

Apelin and pulmonary hypertension
por: Andersen, Charlotte U., et al.
Publicado: (2011)

Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
por: Wiedenroth, Christoph B., et al.
Publicado: (2018)

Levosimendan in pulmonary hypertension and right heart failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)

Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular–Pulmonary Arterial Coupling
por: Taran, Irina N., et al.
Publicado: (2018)

Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices
por: Korsholm, Kasper, et al.
Publicado: (2022)

Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding
por: Rai, Nabham, et al.
Publicado: (2018)

Pulmonary vasodilation in acute pulmonary embolism – a systematic review
por: Lyhne, Mads Dam, et al.
Publicado: (2020)

Large Solid Right Atrial Thrombus Treated by AngioVac Catheter-Based Suction Thrombectomy
por: Schultz, Jacob, et al.
Publicado: (2018)

Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta‐analysis
por: Wang, Wuwan, et al.
Publicado: (2019)

Sex and survival following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Scandinavian observational cohort study
por: Kallonen, Janica, et al.
Publicado: (2021)

Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
por: Kallonen, Janica, et al.
Publicado: (2022)

Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”
por: Rai, Nabham, et al.
Publicado: (2018)

Riociguat for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): A subgroup analysis from the PATENT studies
por: Stephan, Rosenkranz, et al.
Publicado: (2015)

A porcine in-vivo model of acute pulmonary embolism
por: Schultz, Jacob, et al.
Publicado: (2017)

Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy
por: Andersen, Asger, et al.
Publicado: (2022)

NOVEL CTEPH MIMICKERS IN THE COVID-19 ERA
por: Pietrowicz, Rylie, et al.
Publicado: (2022)

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
por: McLaughlin, Vallerie V., et al.
Publicado: (2017)

Catheter-directed mechanical thrombectomy in a patient with high-risk pulmonary embolism complicated by out-of-hospital cardiac arrest: a case report
por: Thangavel, Shifan, et al.
Publicado: (2023)

Putative Biomarkers for Acute Pulmonary Embolism in Exhaled Breath Condensate
por: Gade, Inger Lise, et al.
Publicado: (2021)

Levosimendan improves cardiac function and myocardial efficiency in rats with right ventricular failure
por: Hansen, Mona S., et al.
Publicado: (2017)

Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension – Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study
por: Currie, Brooke, et al.
Publicado: (2021)

Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Riociguat: PATENT-1 Study
por: Said, Karim
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vsc4k4a5qimtooorjtbepgg1db